CDEK
← All organizations

Zambon

For profitContributed to NME

Also known as: Zambon SpA | ZAMBON SPA

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Jan 1, 1997

First marketed drug

Dec 19, 1996

First NDA

Dec 19, 1996

Last known activity

Jan 15, 2021

Timeline

1870s

  1. Jan 1, 1878

    Zambon— Founded

1990s

  1. Dec 19, 1996

    fosfomycin— NDA Organization

2000s

  1. May 1, 2003

    Laphal— Acquired

2010s

  1. Dec 7, 2015

    olopatadine— Marketing Organization

  2. Jul 25, 2019

    Breath Therapeutics Inc— Acquired

Drugs by trial phase (23 distinct, 26 trials)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (4)

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (24)

Details

Founded
Vicenza, IT Jan 1, 1878
First NDA
Dec 19, 1996
Last known activity
Jan 15, 2021